BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 6, 2000
View Archived Issues
Roche highlights significant events in Q3 2000
Read More
Mother-to-child HIV transmission reduced by shorter, less expensive AZT treatment
Read More
Genentech updates product pipeline at investors conference
Read More
Gilead begins phase II studies with liposomal formulation of lurtotecan
Read More
Axonyx actively pursues development of AD treatments, diagnostics
Read More
Combination therapy including Maxamine proves effective and safe in chronic HCV
Read More
Clevudine phase I trial results presented at AASLD meeting
Read More
AASLD news: F-180 displays beneficial effects in portal hypertension-related bleeding
Read More
First clinical trial of EPI-2010 for asthma
Read More
Effects of Ono-8711, a selective EP1 receptor antagonist, on rat urinary bladder
Read More
Siga and Maxygen collaborate on development of novel vaccines
Read More
Fabrazyme advisory committee review not necessary
Read More
Relaxant effects of KRP-197 on human urinary bladder discussed at SIU congress
Read More
Botox provides sustained improvement to patients with drug-resistant detrusor hyperreflexia
Read More
Acorda awarded two NIH grants for CNS repair research
Read More
Degradation and stability of antitumor clinical candidate RH1 described at AAPS meeting
Read More
Idec files Zevalin BLA with FDA; European filing planned
Read More
Novel antitumor alkaloid CWJ-a-5: pharmacokinetics in rats
Read More
Single-dose rhIL-10 does not alter responses to allergen challenge in asthmatics
Read More
Preparation, activity and use of new cGMP-PDE inhibitors in cardiovascular and other disorders
Read More
New heterocyclic compounds from Shionogi with affinity for 5-HT receptors
Read More
Mitsubishi-Tokyo Pharmaceuticals reports synthesis and activity of imidazole M3 antagonists
Read More
SB researchers discover series of rodent anti-human IL-18 antibodies
Read More
Kinase-inhibitory indolinone compounds patented by Sugen
Read More
New MEK inhibitor from DuPont and its use in inflammation and cancer
Read More
Takeda's new GnRH antagonists, their production and use
Read More
New Knoll compound useful for seizures, neurological disorders and neurological damage
Read More
Antiviral agents for hepatitis emerge from R&D at CSIRO
Read More